GRPR and neoplasm: A newly published imaging study confirms that GRP-R targeted PET/CT clinical imaging, using a radiolabeled BN-analogue, successfully detected primary, recurrent and metastatic lesions of PC, and displayed good tumor delineation in a subset of patients with recurrent PC, including lymph node and bone metastatic lesions in patients with PC [52].